Vaginal hysterectomies are associated with superior patient outcomes and cost less than other methods of hysterectomy. So why is their rate of use declining?
Reports of women being criticized for “intense” workouts in late pregnancy are circulating the Web. Are these criticisms clinically warranted, or are the criticizers just bullies?
Physicians’ groups are urging ob/gyns to have difficult conversations with obese women about their weight. Here’s one example of how utter bluntness can be an effective tactic.
Discontinuation rates at 6 months among users of long-acting reversible contraceptive methods are low and not increased among adolescents and young women.
Patients with uterine fibroids have been advised to avoid a hysterectomy as treatment of the condition at all costs. Sound advice or mucky water?
The effectiveness of lamotrigine for bipolar disorder decreases during pregnancy and requires upward dose adjustments until delivery to avoid symptom recurrence.
Medroxyprogesterone acetate (MPA) and tranexamic acid effectively treat heavy menstrual bleeding, but more adverse effects and less patient satisfaction are reported with MPA use.
A fertility pen, redesigned to incorporate updates and new features developed from patient and provider feedback, has been FDA approved and will be available December 2013.
Delivery at or near a high-volume cardiac surgical center offers the best outcome for neonates with hypoplastic left heart syndrome, new research shows.
New research confirms that use of metoclopramide, commonly used for nausea and vomiting, in early pregnancy does not increase risk of major malformations.